Ciphergen's Diagnostic Division.
The Diagnostics Division is the commercialization engine for Ciphergen Biosystems, Inc. Their goal is to identify, develop and commercialize high-value proteomic-based assays that will meet the clinical needs of physicians as they diagnose, treat and monitor their patients. Initially, the Diagnostics Division is focusing its efforts on cancer, cardiovascular disease and Alzheimer's disease.